EPINASTINE Drug Patent Profile
✉ Email this page to a colleague
When do Epinastine patents expire, and what generic alternatives are available?
Epinastine is a drug marketed by Apotex, Chartwell Rx, Epic Pharma Llc, Pharmobedient, Somerset Theraps Llc, and Sun Pharm Inds. and is included in six NDAs.
The generic ingredient in EPINASTINE is epinastine hydrochloride. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the epinastine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Epinastine
A generic version of EPINASTINE was approved as epinastine hydrochloride by SOMERSET THERAPS LLC on October 31st, 2011.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for EPINASTINE?
- What are the global sales for EPINASTINE?
- What is Average Wholesale Price for EPINASTINE?
Summary for EPINASTINE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Drug Prices: | Drug price information for EPINASTINE |
| DailyMed Link: | EPINASTINE at DailyMed |
US Patents and Regulatory Information for EPINASTINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex | EPINASTINE HYDROCHLORIDE | epinastine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 090919-001 | Oct 31, 2011 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmobedient | EPINASTINE HYDROCHLORIDE | epinastine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 090870-001 | Mar 14, 2011 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Chartwell Rx | EPINASTINE HYDROCHLORIDE | epinastine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 203384-001 | Dec 7, 2016 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Epic Pharma Llc | EPINASTINE HYDROCHLORIDE | epinastine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 204055-001 | May 5, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sun Pharm Inds | EPINASTINE HYDROCHLORIDE | epinastine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 091626-001 | Oct 31, 2011 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | EPINASTINE HYDROCHLORIDE | epinastine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 090951-001 | Oct 31, 2011 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
